Xiaofei Hu

1.8k total citations · 3 hit papers
43 papers, 1.2k citations indexed

About

Xiaofei Hu is a scholar working on Soil Science, Ecology and Molecular Biology. According to data from OpenAlex, Xiaofei Hu has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Soil Science, 9 papers in Ecology and 8 papers in Molecular Biology. Recurrent topics in Xiaofei Hu's work include Soil Carbon and Nitrogen Dynamics (20 papers), Dermatology and Skin Diseases (8 papers) and Asthma and respiratory diseases (7 papers). Xiaofei Hu is often cited by papers focused on Soil Carbon and Nitrogen Dynamics (20 papers), Dermatology and Skin Diseases (8 papers) and Asthma and respiratory diseases (7 papers). Xiaofei Hu collaborates with scholars based in China, United States and Canada. Xiaofei Hu's co-authors include Alvina D. Chu, Henrique D. Teixeira, Brian Calimlim, John Liu, Allan R. Tenorio, Kim Papp, Emma Guttman‐Yassky, Chia‐Yu Chu, Meng Liu and Eric L. Simpson and has published in prestigious journals such as The Lancet, The Science of The Total Environment and Plant and Soil.

In The Last Decade

Xiaofei Hu

41 papers receiving 1.2k citations

Hit Papers

Once-daily upadacitinib versus placebo in adolescents and... 2021 2026 2022 2024 2021 2021 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
    2021 350 citations Emma Guttman‐Yassky, Henrique D. Teixeira et al. The Lancet profile →
  2. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
    2021 250 citations Kristian Reich, Henrique D. Teixeira et al. The Lancet profile →
  3. Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
    2022 122 citations Eric L. Simpson, Kim Papp et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Hu China 13 673 456 242 222 150 43 1.2k
Ruxin Zhang China 18 75 0.1× 259 0.6× 49 0.2× 256 1.2× 49 0.3× 74 1.2k
Samira Absalah Netherlands 16 236 0.4× 87 0.2× 17 0.1× 36 0.2× 91 0.6× 24 611
Kim M. O’Sullivan Australia 26 38 0.1× 193 0.4× 273 1.1× 113 0.5× 56 0.4× 62 2.3k
Krystyna Obtułowicz Poland 16 178 0.3× 275 0.6× 221 0.9× 42 0.2× 75 1.0k
Yuya Tada Japan 20 202 0.3× 68 0.1× 42 0.2× 65 0.3× 3 0.0× 52 1.0k
Sonia García‐Rodríguez Spain 17 53 0.1× 8 0.0× 65 0.3× 38 0.2× 181 1.2× 32 827
Zhengqi Wang United States 23 19 0.0× 58 0.1× 56 0.2× 133 0.6× 15 0.1× 48 1.6k
Qing Zhao China 13 101 0.2× 5 0.0× 49 0.2× 37 0.2× 107 0.7× 50 625
Wenfeng Xiao China 17 27 0.0× 12 0.0× 92 0.4× 31 0.1× 18 0.1× 34 962

Countries citing papers authored by Xiaofei Hu

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Hu more than expected).

Fields of papers citing papers by Xiaofei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Hu. The network helps show where Xiaofei Hu may publish in the future.

Co-authorship network of co-authors of Xiaofei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Hu. A scholar is included among the top collaborators of Xiaofei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Hu. Xiaofei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Ying, Chao Liang, Yafeng Liu, et al.. (2025). Ingenol ameliorates silicosis via targeting the PTGS2/PI3K/AKT signaling axis: Implications for therapeutic intervention. Cellular Signalling. 131. 111780–111780. 2 indexed citations
2.
Bai, Ying, Chao Liang, Jiawei Zhou, et al.. (2025). Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis. International Immunopharmacology. 153. 114458–114458. 1 indexed citations
3.
4.
5.
6.
Reich, Kristian, Marjolein de Bruin‐Weller, Mette Deleuran, et al.. (2023). Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in patient‐reported symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trials. Journal of the European Academy of Dermatology and Venereology. 37(8). 1634–1641. 8 indexed citations
7.
Bu, Wensheng, Xiaofei Hu, Fangchao Wang, et al.. (2023). Are small trees more responsive to nutrient addition than large trees in an evergreen broadleaved forest?. Forest Ecology and Management. 543. 121129–121129. 6 indexed citations
8.
Guttman‐Yassky, Emma, Jonathan I. Silverberg, Diamant Thaçi, et al.. (2023). Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial. Journal of the European Academy of Dermatology and Venereology. 37(12). 2558–2568. 12 indexed citations
9.
Blauvelt, Andrew, Barry Ladizinski, Vimal H. Prajapati, et al.. (2023). Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up). Journal of the American Academy of Dermatology. 89(3). 478–485. 23 indexed citations
10.
Xu, Lei, Yang Zhao, Ming Xiong, et al.. (2023). Worldwide research trends on chloroquine: a bibliometric analysis from 2012 to 2021. Traditional Medicine Research. 8(12). 71–71. 3 indexed citations
11.
Lio, Peter, Lawrence F. Eichenfield, Danielle Marcoux, et al.. (2023). 413 Improvement in itch, symptoms and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (Measure Up 1, Measure Up 2 and AD Up). British Journal of Dermatology. 188(Supplement_3). 1 indexed citations
12.
Wang, Shuli, Xi Yuan, Ling Zhang, et al.. (2021). Litter age interacted with N and P addition to impact soil N2O emissions in Cunninghamia lanceolata plantations. Journal of Plant Ecology. 15(4). 771–782. 8 indexed citations
13.
Hu, Xiaofei, et al.. (2021). A rare acute neck pain cause that can have misdiagnosis or missed diagnosis-crowned dens syndrome: description of two cases and a literature analysis. Quantitative Imaging in Medicine and Surgery. 11(10). 4491–4496. 5 indexed citations
14.
Reich, Kristian, Henrique D. Teixeira, Marjolein de Bruin‐Weller, et al.. (2021). Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. 397(10290). 2169–2181. 250 indexed citations breakdown →
15.
Guttman‐Yassky, Emma, Henrique D. Teixeira, Eric L. Simpson, et al.. (2021). Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. The Lancet. 397(10290). 2151–2168. 350 indexed citations breakdown →
16.
Hu, Xiaofei, Anqi Wu, Fangchao Wang, & Fusheng Chen. (2019). The effects of simulated acid rain on internal nutrient cycling and the ratios of Mg, Al, Ca, N, and P in tea plants of a subtropical plantation. Environmental Monitoring and Assessment. 191(2). 99–99. 29 indexed citations
17.
He, Xinwei, Min Zhu, Xiaofei Hu, et al.. (2016). Angiopoietin-like protein 4 serum levels and gene polymorphisms are associated with large artery atherosclerotic stroke. Journal of the Neurological Sciences. 362. 333–338. 9 indexed citations
18.
He, Xinwei, Dan Yu, Weiling Li, et al.. (2016). Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway. Biomedicine & Pharmacotherapy. 83. 257–264. 93 indexed citations
19.
He, Xinwei, En Wang, Yuyan Bao, et al.. (2016). High serum levels of sclerostin and Dickkopf-1 are associated with acute ischaemic stroke. Atherosclerosis. 253. 22–28. 46 indexed citations
20.
Liu, Yü, et al.. (2013). [Temperature sensitivity of CO2 fluxes from rhizosphere soil mineralization and root decomposition in Pinus massoniana and Castanopsis sclerophylla forests].. PubMed. 24(6). 1501–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruxin Zhang Breakdown of academic impact, for papers by Samira Absalah Breakdown of academic impact, for papers by Kim M. O’Sullivan Breakdown of academic impact, for papers by Krystyna Obtułowicz Breakdown of academic impact, for papers by Yuya Tada Breakdown of academic impact, for papers by Sonia García‐Rodríguez Breakdown of academic impact, for papers by Zhengqi Wang Breakdown of academic impact, for papers by Qing Zhao Breakdown of academic impact, for papers by Wenfeng Xiao
Rankless by CCL
2026